during clinical trials 1 and group of healthy volunteers are given different doses of the drug and the effects are reviewed by the MHRA.
during clinical trails 2 small groups of volunteers with the disease are tested to look at the drugs effectiveness. if the reuslts are promising the stage 3 clinical trials are set up.
during clinical trials 3 a large group of patients are randomly seperated into two groups. one group recieving the medicine and the other a placebo. the trail is a double blind randomized controlled trial.
if these results proove successful the drug will be licensed but will continue to be tested after licensing.
Comments
No comments have yet been made